Oncology & Cancer

Second cancer risk persists for Hodgkin's lymphoma survivors

(HealthDay)—Hodgkin's lymphoma survivors have an increased risk of a second cancer, with risk still elevated at 35 years or more after treatment, according to a study published in the Dec. 24 issue of the New England Journal ...

Oncology & Cancer

New target for potential blood cancer treatment

Mutations present in a blood cancer known as follicular lymphoma have revealed new molecular targets for potential treatments, according to researchers at Queen Mary University of London (QMUL) together with collaborators ...

Oncology & Cancer

New type of cancer treatment targets cancer cell proteins

A new therapeutic approach that targets an aggressive form of lymphoma may greatly increase the efficacy of treatment and result in better outcomes for patients, according to new research by scientists at Weill Cornell Medicine.

Oncology & Cancer

New treatment option for subtype of aggressive lymphoma

An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated ...

Oncology & Cancer

Persistent swollen neck glands could indicate cancer

Referring patients with unexplained swollen neck glands for specialist investigations could help to avoid some of the thousands of deaths each year from lymphoma, a type of cancer.

Oncology & Cancer

New cancer fears in France over breast implants (Update)

France's national cancer institute said on Tuesday there was a "clearly established link" between a rare form of cancer and a certain type of breast implant, as the health minister sought to allay fears.

page 12 from 18